Molecular mechanisms of β2-adrenergic receptor function and regulation

Proceedings of the American Thoracic Society

Volumn 2, Issue 4, 2005, Pages 292-296

  McGraw, Dennis W ^a   Liggett, Stephen B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

agonist; Asthma; Chronic obstructive pulmonary disease; G protein coupled receptor; Phospholipase C

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR;

AIRWAY CONSTRICTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DRUG POTENTIATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; BRONCHOSPASM; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ASTHMA; BRONCHOCONSTRICTION; HUMANS; MICE; PHOSPHOLIPASE C; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTOR CROSS-TALK; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 27644565667     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200504-027SR     Document Type: Conference Paper

References (18)

1. 2-adrenergic receptor routes receptors to degradation during agonist regulation. J Biol Chem 2004;279:38603-38607.
2. Rands E, Candelore MR, Cheung AH, Hill WS, Strader CD, Dixon RA. Mutational analysis of β-adrenergic receptor glycosylation. J Biol Chem 1990;265:10759-10764.
3. 341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem 1989;264:7564-7569.
4. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998;38:289-319.
5. 2-adrenergic receptor signaling pathways. J Allergy Clin Immunol 2002;110:S229-S235.
6. 2-adrenergic receptors by β-arrestins. Science 2002;298:834-836.
7. 2-adrenergic receptor and β-arrestin. Science 2001;294:1307-1313.
8. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993;268:23116-23121.
9. + exchange. Nature 1998;392:626-630. c
10. 2C-Adrenergic receptor third loop chimera show that agonist interaction with receptor subtype backbone establishes G protein-coupled receptor kinase phosphorylation. J Biol Chem 2000;275:28989-28993.
11. s. Mol Pharmacol 1994;45:696-702.
12. q receptor signaling via phospholipase C underlies the airway β-agonist paradox. J Clin Invest 2003;112:619-626.
13. Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA. Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 2004;101:4948-4953.
14. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003;43:381-411.
15. Small KM, Rathz DA, Liggett SB. Identification of adrenergic receptor polymorphisms. Methods Enzymol 2002;343:459-475.
16. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
17. 2-adrenoceptor polymorphism. Thorax 2000;55:762-767.
18. Israel E, Chinchilli VM, Ford JG, Boushey A, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, et al. Use of regularly scheduled albuterol treatment in asthma: genotype stratified, randomised, placebo controlled cross-over trial. Lancet 2004;364:1505-1512.